A Multicenter, Multicountry Study to Calibrate Florbetapir (18F) PET Imaging Data to the Centiloid Scale Based on 11C-PiB
Phase of Trial: Phase I
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Florbetapir F 18 (Primary) ; Pittsburgh compound B
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 25 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Feb 2015 Planned End Date changed from 1 Nov 2014 to 1 May 2015 ClinicalTrials.gov record.
- 04 Feb 2015 Planned primary completion date changed from 1 Nov 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.